MedPath

Effect of Ayurvedic treatment in the management of delayed menses

Phase 3
Conditions
Health Condition 1: N914- Secondary oligomenorrhea
Registration Number
CTRI/2024/05/066863
Lead Sponsor
Institute of Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age group greater than or equal to 18 years and less than or equal to 40 years

Married and unmarried females

Patients having 1 or more symptoms below for at least 4 consecutive months

Delayed menses (cycle of more than 35 days)

Absent menses (no menstrual bleeding for at least 4 months)

Scanty menses (duration of menstrual flow 2 days or less )

Patients suitable for Basti procedure

Exclusion Criteria

Pregnancy

Lactational amenorrhoea

Congenital defect in genital tract

Polycystic Ovarian Disease

Primary amenorrhoea

Known case of active malignant disease

Patients having active inflammatory disease. e.g. Acute PID, STD like HIV,

VDRL, HBsAg, HCV and TORCH positive.

Chronic systemic disease like uncontrolled Hypertension (Systolic BP more than

160mmHgandDiastolic BP more than 100mmHg), uncontrolled DM (RBS more than 160mg/dl)

Patients not willing to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To attain normal cyclic menstrual bleeding i.e menses with cyclic interval of 21-35 <br/ ><br> days with a meanof 28 days andduration of the menstrual flow being 4-5 days.Timepoint: 4 months
Secondary Outcome Measures
NameTimeMethod
Improvement in Antral Follicle Count (AFC), values of Follicle Stimulating Hormone <br/ ><br> (FSH) and Estradiol(E2). <br/ ><br> Releif in associated menopausal symptoms as per Modified Kupperman Index.Timepoint: 4 months
© Copyright 2025. All Rights Reserved by MedPath